Brief: Fresh Tracks Announces $8.25 Mln Buyout Of Its Right To Receive Future Sofpironium Bromide Payments From Botanix
21/07/2023 13:06
July 21 (Reuters) - Botanix Pharmaceuticals Ltd
BOT.AX :
* FRESH TRACKS ANNOUNCES $8.25 MILLION BUYOUT OF ITS RIGHT
TO
RECEIVE FUTURE SOFPIRONIUM BROMIDE PAYMENTS FROM BOTANIX
* FRESH TRACKS THERAPEUTICS - UNDER APA AMENDMENT, BOTANIX
TO PAY
$8.25 MILLION IN CASH IN LIEU OF REMAINING AMOUNTS POTENTIALLY
PAYABLE BY BOTANIX TO CO
Source text for Eikon: ID:nGNX55Bfgh
Further company coverage: BOT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx